Prestige Consumer Healthcare (PBH) Exchange Rate Effect (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Exchange Rate Effect came in at $272000.0 in Q4 2025, up 113.1% year-on-year from $127638.3 in Q4 2024, and up 6900.0% quarter-over-quarter from -$4000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Exchange Rate Effect (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $272000.0 for Q4 2025.
- On a quarterly basis, Exchange Rate Effect rose 113.1% year-over-year to $272000.0 in Q4 2025; TTM through Dec 2025 was $1.2 million, a 193.5% increase from a year earlier, with the FY2025 full-year figure at -$573000.0, down 418.33% from the prior year.
- Exchange Rate Effect rose to $272000.0 in Q4 2025 per PBH's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q4 2023 and bottomed at -$2.1 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$72000.0 (2023), against an average of -$76200.0.
- Biggest YoY gain for Exchange Rate Effect was 573.57% in 2024; the steepest drop was 20066.67% in 2024.
- Year by year, Exchange Rate Effect stood at -$230000.0 in 2021, then surged by 446.96% to $798000.0 in 2022, then soared by 77.32% to $1.4 million in 2023, then slumped by 246.71% to -$2.1 million in 2024, then jumped by 113.1% to $272000.0 in 2025.
- Per Business Quant, the three latest PBH Exchange Rate Effect figures stand at $272000.0 (Q4 2025), -$4000.0 (Q3 2025), and $825000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 272,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 272,000.00 |
| Dec 31, 2025 | 272,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 825,000.00 |
| Jun 30, 2025 | 825,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | -2.08 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 711,000.00 |
| Sep 30, 2024 | 711,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Mar 31, 2024 | -605,000.00 |
| Mar 31, 2024 | -605,000.00 |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | -490,000.00 |
| Sep 30, 2023 | -490,000.00 |